What we dreamed...

...what we created!

A New Center for Families

The Pediatric Oncology and Hematology clinic has moved to a new location! RaiseRED’s clinic now resides on the fourth floor of the Novak Center for Children’s Health, located at 411 E Chestnut St. across from Kornhauser Library on University of Louisville’s Health Science Campus. The Novak Center was opened in August of this year and has become a new home for the patients, their families, and the staff of the clinic. Because of the generous efforts of raiseRED’s supporters, a full-time social worker supports the clinic and its patients, snacks provided by raiseRED stock the shelf for the kids of the clinic and much more. Tangible signs of raiseRED and the clinic’s work were seen when Kentucky became one of the first states to allocated funding specifically for pediatric oncology research. Thank you to all that have supported raiseRED and the clinic to accomplish this feat, as well as the daily feats of care and treatment. The fight to end childhood cancer and blood diseases is still ongoing please help us continue this fight!

 

Take an inside look at the Novak Center

 
 

Research Highlight

A message from our director

We continue our mission by helping and supporting our patients and their families with the financial resources provided by raiseRED. We were able to do many exciting things for clinical care and research using raiseRED funds. 

RaiseRED support has enabled the Division of Pediatric Hemtaology/Oncology and Stem Cell Transplatation to hire a state-of-the-art researcher and clinican - Dr. WIlliam T. Tse.

Funding from raiseRED continues to hep provide much needed services for our patients and families.

-Dr. Ashok Raj 

Overview of Dr. Raj's Research

Enhancing Tumor Antigen Specific T Cell Repsonses following Autologous SCT

Determine the feasibility of expanding cytotoxic T lymphocytes (CTL) specific for the cancer testis (CT) antigens MAGE-A1, MAGE-A3, and NY-ESO-1 from blood specimens derived from previously treated neuroblastoma and sarcoma patients. 

Overview

AIM 1:

Investigate whether agents which myeloid-derived suppressor cells' (MDSCs) function can facilitate  proliferation and cytokine production by T cells from patients with neuroblastoma and sarcoma. 

Overview

AIM 2: